Springbok Capital Management »

C4 Therapeutics shares owned by Springbok Capital Management

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Springbok Capital Management from 13F filings

Historical chart of Springbok Capital Management investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Springbok Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Springbok Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $81k 31k 2.63
2023-09-30 $95k 51k 1.86
2023-06-30 $94k 34k 2.75